Building on the success of 2018, the 2019 Clinical Biomarkers & World CDx Boston iteration will continue to cement the biomarker and translational development content at the heart of the meeting, enabling attendees to take a journey along the whole development continuum from exploratory biomarker, through clinical validation, past regulatory and reimbursement hurdles and into a globally adopted precision medicine-Dx product.
For 2019 we have two overarching content themes that underpin the whole meeting:
- Proving the predictiveness of novel clinical biomarkers to accelerate the development and approval of innovative targeted therapeutics
- Making diagnostics more fit-for-purpose to increase the adoption and access of Dx-enabled precision medicines in healthcare
The four-day meeting is split into two halves: pre-conference and main conference. Our pre-conference days will contain half-day workshop sessions, designed to take deep, interactive dives into a specific subject area. The main two-day conference is separated into three streams covering translation, clinical development and commercialisation.
Click below to find out more about the biomarker and diagnostic sides to the event.